Concepedia

Wendi Qian

WQ

Statistics

Publications

51

Citations

8K

H-Index

31

Active since

2000

Affiliations

University College London(Current)

Cambridge University Hospitals NHS Foundation Trust

Cancer Research UK

MRC Clinical Trials Unit at UCL

University of Cambridge

Wendi Qian is an author at University College London specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2000–2024

51

Publications

51

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

Timothy Perren, Ann Marie Swart, Jacobus Pfisterer et al. · New England Journal of Medicine · 2011 · 2.1K citations · Full text

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

Gordon Rustin, Maria EL van der Burg, Clare Griffin et al. · The Lancet · 2010 · 584 citations · Full text

, , +8

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

David Cunningham, Eliza A. Hawkes, Andrew Jack et al. · The Lancet · 2013 · 546 citations · Full text

High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial

Harry C. Schouten, Wendi Qian, Stein Kvaløy et al. · Journal of Clinical Oncology · 2003 · 479 citations

Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial

Lisa Lowry, Paul Smith, Wendi Qian et al. · Radiotherapy and Oncology · 2011 · 381 citations

, , +9

1–5 of 51